Home
Home » companies

JNJ

Novartis: 2 Novel Cancer Therapies Show Promising Results

Novartis: 2 Novel Cancer Therapies Show Promising Results
Seeking Alpha

What Is Johnson & Johnson's Opportunity In Hepatitis C Market?

What Is Johnson & Johnson's Opportunity In Hepatitis C Market?
Forbes

J&J taps UK research hubs

J&J taps UK research hubs
The Telegraph, UK

EU regulators fine J&J, Novartis 16 mln euros for generic drug deal

EU regulators fine J&J, Novartis 16 mln euros for generic drug deal
Yahoo/Reuters

J&J, Roche, Novartis tout key cancer-drug data at ASH

J&J, Roche, Novartis tout key cancer-drug data at ASH
Fierce Pharma

How Risperdal Whistle-Blowers Made Millions From J&J

How Risperdal Whistle-Blowers Made Millions From J&J
Bloomberg

J&J’s Drug Shows Promise for Rare Castleman Disease

J&J’s Drug Shows Promise for Rare Castleman Disease
Bloomberg

Johnson & Johnson Battles St. Jude for Cardiac Mapping Leadership

Johnson & Johnson Battles St. Jude for Cardiac Mapping Leadership
Motley Fool

What Everybody Ought to Know About Gilead and Johnson & Johnson's New Hepatitis C Drugs

What Everybody Ought to Know About Gilead and Johnson & Johnson's New Hepatitis C Drugs
Seeking Alpha

Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants

Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants
Forbes